Platelet binding of IgG from patients with heparin-induced thrombocytopenia

Journal of Laboratory and Clinical Medicine

Volumn 127, Issue 5, 1996, Pages 435-442

  Horne III, McDonald K ^a   Alkins, Brenda R ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G; RADIOACTIVE IODINE; THROMBOCYTE FACTOR 4;

ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; HUMAN; IMMUNOLOGY; METABOLISM; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTOPENIA;

BLOOD PLATELETS; HEPARIN; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN G; IODINE RADIOISOTOPES; PLATELET ACTIVATION; PLATELET FACTOR 4; THROMBOCYTOPENIA;

EID: 0030136628     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(96)90060-8     Document Type: Article

References (27)

1. Schmitt BP, Adelman B. Heparin-associated thrombocytopenia: a critical review and pooled analysis. Am J Med Sci 1993;305:208-15.
2. Amiral J, Bridey F, Dreyfus M, et al. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost 1992; 68:95-6.
3. Greinacher A, Potzsch B, Amiral J, Dummel V, Eichner A, Mueller-Eckhardt C. Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen. Thromb Haemost 1994;71:247-51.
4. Moore S, Pepper DS, Cash JD. Platelet antiheparin activity. The isolation and characterization of platelet factor 4 released from thrombin-aggregated washed human platelets and its dissociation into subunits and the isolation of membrane-bound antiheparin activity. Biochim Biophys Acta 1975;379:370-84.
5. George JN, Onofre AR. Human platelet surface binding of endogenous secreted factor VIII-von Willebrand factor and platelet factor 4. Blood 1982;59:194-7.
6. Capitanio AM, Niewiarowski S, Rucinski B, et al. Interaction of platelet factor 4 with human platelets. Biochim Biophys Acta 1985;839:161-73.
7. Stuckey JA, Charles RST, Edwards BFP. A model of the platelet factor 4 complex with heparin. Proteins 1992;14:277-87.
8. Home MK, Chao ES. Heparin binding to resting and activated platelets. Blood 1989;74:238-43.
9. Kelton JG, Smith JW, Warkentin TE, Haywood CPM, Denomme GA, Horsewood P. Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4. Blood 1994;83:3232-9.
10. Green D, Harris K, Reynolds N, Roberts M, Patterson R. Heparin immune thrombocytopenia: evidence for a heparin-platelet complex as the antigenic determinant. J LAB CLIN MED 1978;91:167-75.
11. Howe SE, Lynch DM. An enzyme-linked immunosorbent assay for the evaluation of thrombocytopenia induced by heparin. J LAB CLIN MED 1985;105:554-9.
12. Visentin GP, Ford SE, Scott JP, Aster RH. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. J Clin Invest 1994;93:81-8.
13. Home MK, Alkins BR. Importance of PF4 in heparin-induced thrombocytopenia: confirmation with gray platelets. Blood 1995;85:1408-9.
14. Sheridan D, Carter C, Kelton JG. A diagnostic test for heparin-induced thrombocytopenia. Blood 1986;67:27-30.
15. Corash L, Tan H, Gralnick HR. Heterogeneity of whole blood platelet subpopulations. I. Relationship between buoyant density, cell volume, and ultrastructure. Blood 1977;49: 71-87.
16. Mustard JF, Perry DW, Ardlie NG, Packham MA. Preparation of suspensions of washed platelets from humans. Br J Haematol 1972;22:193-204.
17. Home MK. The effect of secreted heparin-binding proteins on heparin binding to platelets. Thromb Res 1993;70:91-8.
18. Tomiyama Y, Kunicki TJ, Zipf TF, Ford SB, Aster RH. Response of human platelets to activating monoclonal antibodies: importance of Fc RII (CD32) phenotype and a level of expression. Blood 1992;80:2261-8.
19. Kelton JG, Sheridan DP, Santos AV, et al. Heparin-induced thrombocytopenia: laboratory studies. Blood 1988;72:925-30.
20. Chong BH, Ismail F, Chesterman CN, Berndt MC. Heparin-induced thrombocytopenia: mechanism of interaction of the heparin-dependent antibody with platelets. Br J Haematol 1989;73:235-40.
21. Chong BH, Castaldi PA, Berndt MC. Heparin-induced thrombocytopenia: effects of rabbit IgG, and its Fab and Fc fragments on antibody-heparin-platelet interaction. Thromb Res 1989;55:291-5.
22. Smith ME, Reid DM, Jones CE, Jordan JV, Kautz CA, Shulman NR. Binding of quinine- and quinidine-dependent drug antibodies to platelets is mediated by the Fab domain of the immunoglobulin G and is not Fc dependent. J Clin Invest 1987;79:912-7.
23. Greinacher A, Michels I, Liebenhoff U, Presek P, Mueller-Eckhardt C. Heparin-associated thrombocytopenia: immune complexes are attached to the platelet membrane by the negative charge of highly sulphated oligosaccharides. Br J Haematol 1993;84:711-6.
24. Amiral J, Bridey F, Wolf M, et al. Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases. Thromb Haemost 1995;73:21-8.
25. Dawes J, Pumphrey CW, McLaren KM, Prowse CV, Pepper DS. The in vivo release of human platelet factor 4 by heparin. Thromb Res 1982;27:65-76.
26. Rao AK, Niewiarowski S, James P, et al. Effect of heparin on the in vivo release and clearance of human platelet factor 4. Blood 1983;61:1208-14.
27. Boshkov LK, Warkentin TE, Hayward CPM, Andrew M, Kelton JG. Heparin-induced thrombocytopenia and thrombosis: clinical and laboratory studies. Br J Haematol 1993;84: 322-8.